Open AccessCombining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer
Author(s) -
Wen-Cheng Huang,
Ping Liu,
MinHua Zong,
Qianqian Chen,
Hong Zhou,
Hui Kong,
Weiping Xie
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s300153
Subject(s) - medicine , lactate dehydrogenase , chemotherapy , lung cancer , fibrinogen , proportional hazards model , oncology , multivariate analysis , univariate analysis , radiation therapy , performance status , gastroenterology , survival analysis , biology , biochemistry , enzyme
A growing interest exists in identifying reliable and low-cost biomarkers or factors that could predict the therapeutic response, prognosis, recurrence, and survival in small-cell lung cancer (SCLC). This study aimed to investigate the better predictors of chemotherapy efficacy and prognosis in patients with SCLC receiving first-line chemotherapy and radiotherapy.